Determination of potential genotoxic impurity in ecabet sodium active pharmaceutical ingredient by HPLC-MS/MS

Ding Xiying,Ji Xiaolong,Li Bo,Mao Baiyang,Yan Fang,Di Bin

DOI: https://doi.org/10.11665/j.issn.1000-5048.20180310

2018-01-01

Abstract:To develop a sensitive analytical method for the determination of the genotoxic impurity mono ethyl ester of ecabet (Imp-I) , an HPLC-MS/MS technique was employed. Imp-I was synthesized according to the previous literatures. MS/MS and NMR were used to confirm the structure of Imp-I. A Thermo C-18 column was used for chromatographic separations. The mobile phase consisting of A:5 mmol/L ammonium acetate (pH adjusted to 3. 0 with formic acid) and B: acetonitrile, with a gradient program: 0 min 50% B, 4 min 50% B, 12 min 80% B, 16 min 80% B, 16. 1 min 50% B and 20 min 50% B. The column was maintained at 40 degrees C throughout the analysis. All measurements were carried out with the mass spectrometer operated under the negative ESI mode. The selective reaction monitor (SRM) transition was used. Good linearity was obtained for Imp-I over the concentration range of 4-150 ng/mL with the coefficient of determination (r) of 0. 999. And the LOQ was 4 ng/mL. A rapid and sensitive HPLC-ESI-MS/MS method was developed for quantitative analysis of Imp-I in ecabet sodium APIs. This method can be of used for quality assurance of ecabet sodium in bulk commercial drugs.